Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an application for human tr...
Continue reading...
Continue reading...